Search

Author/Creator Greene, Julia M.

1. Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. (5th July 2019)

Authors:
Brown, Tommy A.; Byrd, Kevin; Vreeland, Timothy J.; Clifton, Guy T.; Jackson, Doreen O.; Hale, Diane F.; Herbert, Garth S.; Myers, John W.; Greene, Julia M.; Berry, John S.; Martin, Jonathan; Elkas, John C.; Conrads, Thomas P.; Darcy, Kathleen M.; Hamilton, Chad A.; Maxwel, George L.; Peoples, Ge...
Journal:
Cancer medicine
Issue:
Volume 8:Number 10(2019:Aug.)
Page Start:
4678
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors. Issue 23 (31st May 2018)

Authors:
Herbert, Garth S.; Vreeland, Timothy J.; Clifton, Guy T.; Greene, Julia M.; Jackson, Doreen O.; Hardin, Mark O.; Hale, Diane F.; Berry, John S.; Nichol, Pauline; Yin, Sook; Yu, Xianzhong; Wagner, Thomas E; Peoples, George E.
Journal:
Vaccine
Issue:
Volume 36:Issue 23(2018)
Page Start:
3247
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search